FindTrial
Sign In

A clinical comparative study of two different doses of buprenorphine drug with hyperbaric bupivacaine in spinal Anaesthetisa for surgeries below umbilicus

A CLINICAL COMPARATIVE STUDY OF INTRATHECAL HYPERBARIC BUPIVACAINE WITH DIFFERENT DOSES OF BUPRENORPHINE FOR INFRAUMBILICAL SURGERIES ON CONCURRENT ADMINISTRATION

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028292
Enrollment
70
Registered
2020-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K35-K38- Diseases of appendix Health Condition 2: K00-K95- Diseases of the digestive system Health Condition 3: N00-N99- Diseases of the genitourinary system Health Condition 4: M00-M99- Diseases of the musculoskeletal system and connective tissue Health Condition 5: K40-K46- Hernia

Interventions

Intervention1: Comparison of two different doses of buprenorphine with hyperbaric bupivacaine in spinal anaesthetisa: A.To evaluate the onset and duration of sensory and motor blockade. B. To evaluat

Sponsors

MASHABI J NADAF
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status 1 and 2 of either sex scheduled for infraumbilical surgeries

Exclusion criteria

Exclusion criteria: Gross spinal deformities History of perineural neuropathy Sepsis at site of infection Coagulopathy History of allergies to LA and opiods Emergency cases Pregnant and lactating females

Design outcomes

Primary

MeasureTime frame
Clinical comparative study of intrathecal hyperbaric bupivacaine with different doses of buprenorphine(30mcg and 60mcg) for infraumbilical surgeries on concurrent administrationTimepoint: From onset of action of spinal Anaesthetisa in OT till the motor and sensory recovery of the patient in recovery room—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactMASHABI J NADAF

Kempegowda institute of medical science and research hospital

ambunagaraj67@gmail.com9480383382

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026